As mentioned, loss of H3K27me3 modifications has been associated with meningioma recurrence in retrospective clinical studies [25,26], and hypermethylation of TIMP3, CDKN2A, and TP73 has been correlated with meningioma grade [27,28]. The gene discussed is TIMP3; the disease is meningioma.